Potential use of the SARS-CoV-2 monoclonal antibody sipavibart in people with multiple sclerosis: definition of different patient archetypes from an Italian expert group perspective - Zanetta, Chiara; Gasperini, Claudio; Amato, Maria Pia; Centonze, Diego; Gallo, Paolo; Patti, Francesco; Riva, Agostino; Filippi, Massimo (Journal of neurology, 2025)
Keywords: Antibodies, Monoclonal - therapeutic use; Antibodies, Monoclonal, Humanized - therapeutic use; Antiretroviral drugs; CD20 antigen; Cladribine; Comorbidity; COVID-19; COVID-19 - immunology; COVID-19 - prevention & control; COVID-19 vaccines; Disease prevention; Female; Humans; Immunization; Immunocompromised Host; Immunomodulation; Italy; Male; Medicine; Medicine & Public Health; Monoclonal antibodies; Multiple sclerosis; Multiple Sclerosis - complications; Multiple Sclerosis - drug therapy; Multiple Sclerosis - epidemiology; Multiple Sclerosis - immunology; Neurology; Neuromodulation; Neuromyelitis; Neuroradiology; Neurosciences; Patients; Pediatrics; Pre-Exposure Prophylaxis - methods; Prophylaxis; Risk factors; SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2; Short Commentary; Steroid hormones; Vaccination; Italy; Pre-exposure profilaxis; Sipavibart; Multiple sclerosis; SARS-CoV-2